Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia
- Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr. Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023...
7th Edition of Fintech Abu Dhabi Explores Synergy Between Finance and Technology
ABU DHABI, United Arab Emirates, Nov. 30, 2023 /PRNewswire/ -- Building upon the successes of MENA's biggest Fintech Festival presented by Abu Dhabi Global Market (ADGM), the 7th edition of Fintech Abu Dhabi welcomed an impressive turnout of...
Jayud Enters into Strategic Partnership with Shandong Oranda Logistics
SHENZHEN, China, Nov. 29, 2023 /PRNewswire/ -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced a...
Xuzhou, Jiangsu: Supporting Local Economic Development via High-Quality Power Supplies
XUZHOU, China, Nov. 29, 2023 /PRNewswire/ -- Electricity plays a crucial role in promoting economic development. In recent years, the State Grid Xuzhou Power Supply Company has been committed to accelerating the construction of power infrastructure,...
ORCODA Ranks 54th in Australian Financial Review's Prestigious Fast 100 List
BRISBANE, Australia, Nov. 29, 2023 /PRNewswire/ -- ORCODA Limited (ASX: ODA), a leading provider of integrated smart transport technology solutions, has been recognised for its exceptional growth by earning a coveted position on The Australian...
VISTA Eye Specialist Unveils Innovative Solution for Reading Problems
PETALING JAYA, Malaysia, Nov. 29, 2023 /PRNewswire/ -- VISTA Eye Specialist (VISTA) proudly introduces the groundbreaking EVO Viva Implantable Collamer Lens (Viva) to address the dual challenge of short-sightedness and reading problems (presbyopia)...
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics® technology. PRISM BioLab receives upfront payments and up to $660 million in total milestones, plus...
Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally
SINGAPORE, Nov. 29, 2023 /PRNewswire/ -- Wonder Technologies PTE. LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based in Singapore, has reached a breakthrough in its acoustics-based AI for depression...